Harrow Inc (HROW)
16.77
+0.61
(+3.77%)
USD |
NASDAQ |
May 17, 16:00
16.77
0.00 (0.00%)
After-Hours: 20:00
Harrow Cash from Investing (TTM): -21.69M for March 31, 2024
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
March 31, 2024 | -21.69M |
December 31, 2023 | -152.55M |
September 30, 2023 | -152.36M |
June 30, 2023 | -133.29M |
March 31, 2023 | -132.30M |
December 31, 2022 | -1.743M |
September 30, 2022 | -15.94M |
June 30, 2022 | -27.80M |
March 31, 2022 | -18.87M |
December 31, 2021 | -18.69M |
September 30, 2021 | -4.579M |
June 30, 2021 | 8.074M |
March 31, 2021 | -0.932M |
December 31, 2020 | -0.981M |
September 30, 2020 | -1.86M |
June 30, 2020 | -1.658M |
March 31, 2020 | -1.782M |
December 31, 2019 | -1.833M |
September 30, 2019 | -1.716M |
June 30, 2019 | -2.284M |
March 31, 2019 | -2.259M |
December 31, 2018 | -2.199M |
September 30, 2018 | -1.596M |
June 30, 2018 | -1.146M |
March 31, 2018 | -1.009M |
Date | Value |
---|---|
December 31, 2017 | -0.961M |
September 30, 2017 | -0.876M |
June 30, 2017 | -1.824M |
March 31, 2017 | -5.082M |
December 31, 2016 | -7.289M |
September 30, 2016 | -7.996M |
June 30, 2016 | -7.897M |
March 31, 2016 | -4.52M |
December 31, 2015 | -5.13M |
September 30, 2015 | -4.341M |
June 30, 2015 | -3.372M |
March 31, 2015 | -3.892M |
December 31, 2014 | -0.91M |
September 30, 2014 | -0.8375M |
June 30, 2014 | -0.7658M |
March 31, 2014 | -0.0696M |
December 31, 2013 | -0.07M |
September 30, 2013 | -0.0607M |
June 30, 2013 | -0.0554M |
March 31, 2013 | -0.0523M |
December 31, 2012 | -0.0155M |
September 30, 2012 | -0.0153M |
June 30, 2012 | -0.0153M |
March 31, 2012 | -0.0146M |
December 31, 2011 | 0.00 |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-152.55M
Minimum
Dec 2023
8.074M
Maximum
Jun 2021
-34.24M
Average
-3.432M
Median
Cash from Investing (TTM) Benchmarks
Aquestive Therapeutics Inc | -1.022M |
Cyclacel Pharmaceuticals Inc | -0.006M |
Lifecore Biomedical Inc | -4.153M |
Relmada Therapeutics Inc | 20.51M |
Corvus Pharmaceuticals Inc | 10.93M |